Market Closed -
Japan Exchange
11:30:00 22/05/2024 am IST
5-day change
1st Jan Change
1,437
JPY
-2.24%
+1.34%
+2.72%
Nihon Chouzai Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2021
January 29, 2021 at 11:30 am IST
Nihon Chouzai Co.,Ltd. provided consolidated earnings guidance for the fiscal year ending March 31, 2021. For the year, the company expects net sales of JPY 275,753 million, operating profit of JPY 6,552 million, profit attributable to owners of parent of JPY 3,260 million against net income per share of JPY 108.73.
Japanese Shares Muted Amid Firm Yen, Mixed Wall Street
02/05
MT
Nihon Chouzai's Fiscal 2024 Attributable Profit Misses Forecast on Extraordinary Losses
02/05
MT
NIHON CHOUZAI Co.,Ltd. Provides Consolidated Earnings Guidance for the First Half of Fiscal 2025 and the Full Year Ending March 31, 2025
30/04
CI
NIHON CHOUZAI Co.,Ltd. Announces Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 26, 2024; Provides Dividend Guidance for the Second Quarter and Fiscal Year Ending March 31, 2025
30/04
CI
Nihon Chouzai to Meet Tradable Share Ratio Requirement by June
25/03
MT
NIHON CHOUZAI Co.,Ltd Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 6, 2023; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024
31/23/31
CI
NIHON CHOUZAI Co.,Ltd. Provides Earnings Guidance for the Year Ending March 31, 2024
31/23/31
CI
NIHON CHOUZAI Co.,Ltd. Provides Consolidated Earnings Guidance for the First Half of Fiscal 2024 and the Full Year Ending March 31, 2024
31/23/31
CI
NIHON CHOUZAI Co.,Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal 2024 and the Full Year Ending March 31, 2024
31/23/31
CI
NIHON CHOUZAI Co.,Ltd. Announces Dividend for the Year Ended March 31, 2023, Payable on June 26, 2023; Provides Dividend Guidance for the Second Quarter of Fiscal 2024 and Full Year Ending March 31, 2024
28/23/28
CI
NIHON CHOUZAI Co.,Ltd. Provides Consolidated Earnings Guidance for the First Half of Fiscal 2024 and the Full Year Ending March 31, 2024
28/23/28
CI
NIHON CHOUZAI Co.,Ltd. Provides Dividend Guidance for the Year Ending March 31, 2023
31/23/31
CI
NIHON CHOUZAI Co.,Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023
31/23/31
CI
NIHON CHOUZAI Co.,Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023
31/22/31
CI
Nihon Chouzai Co.,Ltd. Announces Dividend for the Second Quarter Ended of the Fiscal Year 2023, Payable on December 6, 2022; Provides Dividend Guidance for the Year Ending March 31, 2023
31/22/31
CI
NIHON CHOUZAI Co.,Ltd. Provides Consolidated Earnings Forecast for the First Half and Full Year of Fiscal Year Ending March 31, 2023
29/22/29
CI
NIHON CHOUZAI Co.,Ltd. Provides Dividend Guidance for the Second Quarter and Year-End of Fiscal Year Ending March 31, 2023
29/22/29
CI
Nihon Chouzai Co.,Ltd. Announces Dividend for the Year Ended March 31, 2022, Payable on June 24, 2022; Provides Dividend Guidance for the Second Quarter and Full Year Ending March 31, 2023
28/22/28
CI
Nihon Chouzai Co.,Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2023
28/22/28
CI
Nihon Chouzai to Adopt an Executive Officer System
22/22/22
MT
Nihon Chouzai Co.,Ltd. Provides Dividend Guidance for the Year Ending March 31, 2022
31/22/31
CI
Nihon Chouzai Co.,Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2022
31/22/31
CI
Nihon Chouzai Co.,Ltd. Announces for the Second Quarter Ended September 30, 2021, Payable on December 6, 2021; Provides Dividend Guidance for the Year Ending March 31, 2022
29/21/29
CI
Nihon Chouzai Co.,Ltd. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2022
29/21/29
CI
Nihon Chouzai Co.,Ltd. agreed to acquire remaining 44.71% stake in Choseido Pharmaceutical Co., Ltd. for ¥5.8 billion.
21/21/21
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
NIHON CHOUZAI Co., Ltd is primarily engaged in the pharmacy business, the provision of staffing services, as well as the manufacture and sale of pharmaceutical products. The Company operates in three business segments. The Pharmacy segment is engaged in the operation of a chain of dispensing pharmacies. The Pharmaceutical Product Manufacturing and Distribution segment is engaged in the manufacture and nationwide sale of generic pharmaceutical products. The Healthcare Personnel Staffing Service segment is involved in the dispatching of pharmacists to various regional pharmacies.
More about the company
Last Close Price
1,470
JPY
Average target price
1,520
JPY
Spread / Average Target
+3.40%
Consensus
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
NIHON CHOUZAI CO.,LTD. 
